Search Results Search Sort by RelevanceMost Recent Medical Education Dec 2009 HIV/AIDS Ethics Education Divya Ahuja, MD, Sabra Smith, MS, RN, and Charles S. Bryan, MD The University of South Carolina at Columbia School of Medicine integrated HIV ethics into its curriculum. Virtual Mentor. 2009;11(12):953-957. doi: 10.1001/virtualmentor.2009.11.12.medu2-0912. Case and Commentary Nov 2003 Please Don't Say Anything: Partner Notification and the Patient-Physician Relationship, Commentary 1 Ronald Epstein, MD When a public health risk exists, a physician's obligations to warn those in potential danger overrides rules of patient confidentiality. Virtual Mentor. 2003;5(11):485-488. doi: 10.1001/virtualmentor.2003.5.11.ccas2-0311. Case and Commentary Nov 2003 Please Don't Say Anything: Partner Notification and the Patient-Physician Relationship, Commentary 3 Gregory W. Rutecki, MD When a public health risk exists, a physician's obligations to warn those in potential danger overrides rules of patient confidentiality. Virtual Mentor. 2003;5(11):492-495. doi: 10.1001/virtualmentor.2003.5.11.ccas2-0311. Case and Commentary Nov 2003 Please Don't Say Anything: Partner Notification and the Patient-Physician Relationship, Commentary 2 James C. Thomas, MPH, PhD When a public health risk exists, a physician's obligations to warn those in potential danger overrides rules of patient confidentiality. Virtual Mentor. 2003;5(11):489-491. doi: 10.1001/virtualmentor.2003.5.11.ccas2-0311. Podcast Jul 2024 Author Interview: “How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD?” Dr Katherin M. Duthie joins Ethics Talk to discuss her article, coauthored with Dr Kathryn A. Dong: “How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD?” Case and Commentary Jul 2024 How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD? Kathryn A. Dong, MD, MSc and Katherine M. Duthie, PhD, HEC-C Severe withdrawal, risk of patient-initiated discharge, and some inpatients’ uses of substances prompt questions considered in this commentary. AMA J Ethics. 2024;26(7):E512-519. doi: 10.1001/amajethics.2024.512. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Current page 5
Medical Education Dec 2009 HIV/AIDS Ethics Education Divya Ahuja, MD, Sabra Smith, MS, RN, and Charles S. Bryan, MD The University of South Carolina at Columbia School of Medicine integrated HIV ethics into its curriculum. Virtual Mentor. 2009;11(12):953-957. doi: 10.1001/virtualmentor.2009.11.12.medu2-0912.
Case and Commentary Nov 2003 Please Don't Say Anything: Partner Notification and the Patient-Physician Relationship, Commentary 1 Ronald Epstein, MD When a public health risk exists, a physician's obligations to warn those in potential danger overrides rules of patient confidentiality. Virtual Mentor. 2003;5(11):485-488. doi: 10.1001/virtualmentor.2003.5.11.ccas2-0311.
Case and Commentary Nov 2003 Please Don't Say Anything: Partner Notification and the Patient-Physician Relationship, Commentary 3 Gregory W. Rutecki, MD When a public health risk exists, a physician's obligations to warn those in potential danger overrides rules of patient confidentiality. Virtual Mentor. 2003;5(11):492-495. doi: 10.1001/virtualmentor.2003.5.11.ccas2-0311.
Case and Commentary Nov 2003 Please Don't Say Anything: Partner Notification and the Patient-Physician Relationship, Commentary 2 James C. Thomas, MPH, PhD When a public health risk exists, a physician's obligations to warn those in potential danger overrides rules of patient confidentiality. Virtual Mentor. 2003;5(11):489-491. doi: 10.1001/virtualmentor.2003.5.11.ccas2-0311.
Podcast Jul 2024 Author Interview: “How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD?” Dr Katherin M. Duthie joins Ethics Talk to discuss her article, coauthored with Dr Kathryn A. Dong: “How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD?”
Case and Commentary Jul 2024 How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD? Kathryn A. Dong, MD, MSc and Katherine M. Duthie, PhD, HEC-C Severe withdrawal, risk of patient-initiated discharge, and some inpatients’ uses of substances prompt questions considered in this commentary. AMA J Ethics. 2024;26(7):E512-519. doi: 10.1001/amajethics.2024.512.